WallStSmart

Covista Inc. (CVSA)vsRuanyun Edai Technology Inc. Ordinary shares (RYET)

VS
⚡

Smart Verdict

WallStSmart Research — data-driven comparison

Covista Inc. generates 26677% more annual revenue ($2.00B vs $7.48M). CVSA leads profitability with a 12.8% profit margin vs -105.0%. CVSA earns a higher WallStSmart Score of 71/100 (B).

CVSA

Strong Buy

71

out of 100

Grade: B

Growth: 7.3Profit: 7.5Value: 7.0Quality: 6.0
Piotroski: 4/9Altman Z: 3.06

RYET

Avoid

28

out of 100

Grade: F

Growth: 5.3Profit: 2.0Value: 5.0Quality: 4.0
Piotroski: 2/9Altman Z: -2.85

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CVSA4 strengths · Avg: 8.5/10
Altman Z-ScoreHealth
3.0610/10

Safe zone — low bankruptcy risk

PEG RatioValuation
0.838/10

Growing faster than its price suggests

P/E RatioValuation
13.9x8/10

Attractively priced relative to earnings

Price/BookValuation
2.8x8/10

Reasonable price relative to book value

RYET1 strengths · Avg: 10.0/10
Revenue GrowthGrowth
176.2%10/10

Revenue surging 176.2% year-over-year

Areas to Watch

CVSA0 concerns · Avg: 0/10

No major concerns identified

RYET4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$19.49M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Return on EquityProfitability
-138.1%2/10

ROE of -138.1% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : CVSA

The strongest argument for CVSA centers on Altman Z-Score, PEG Ratio, P/E Ratio. Revenue growth of 10.7% demonstrates continued momentum. PEG of 0.83 suggests the stock is reasonably priced for its growth.

Bull Case : RYET

The strongest argument for RYET centers on Revenue Growth. Revenue growth of 176.2% demonstrates continued momentum.

Bear Case : CVSA

No major red flags identified for CVSA, but monitor valuation.

Bear Case : RYET

The primary concerns for RYET are EPS Growth, Market Cap, Piotroski F-Score.

Key Dynamics to Monitor

CVSA profiles as a value stock while RYET is a hypergrowth play — different risk/reward profiles.

RYET is growing revenue faster at 176.2% — sustainability is the question.

CVSA generates stronger free cash flow (76M), providing more financial flexibility.

Monitor EDUCATION & TRAINING SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

CVSA scores higher overall (71/100 vs 28/100) and 10.7% revenue growth. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Covista Inc.

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · USA

Covista Inc., provides healthcare education in the United States, Barbados, St. Kitts, and St. Maarten. The company is headquartered in Chicago, Illinois.

Ruanyun Edai Technology Inc. Ordinary shares

CONSUMER DEFENSIVE · EDUCATION & TRAINING SERVICES · China

Ruanyun Edai Technology Inc. is a data driven artificial intelligence technology company focused on kindergarten through year twelve education (K-12) in China. The company is headquartered in Nanchang, China.

Visit Website →

Want to dig deeper into these stocks?